A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth
An important agenda of pharmaceutical companies is the establishment of therapeutic area strategies, drug modality, and geographic strategies for research and development. It is worthwhile to understand the changes in therapeutic area, modality and internationalization of the top-selling pharmaceutical drugs over the past. Hence, the purposes of this study are to investigate changes in therapeutic area, modality and internationalization of the top-selling drugs and to identify their life cycle patterns. We compared the top-selling drugs between 2011 and 2017, and found that the percentages of nichebuster cancer drugs and home region-oriented drugs have increased whereas the proportions of traditional blockbuster cardiovascular drugs and global drugs have decreased. We compared product life cycle patterns via a Kruskal–Wallis test, and identified the features of product life cycle patterns per therapeutic area and modality. We performed a case study on drugs in the same class with the same pharmacological mechanism but found no differences across cases. Our results provide insights into therapeutic area strategies that consider life cycle patterns and geographic strategies that consider the competitive advantages of home region-oriented drugs. Finally, we presented new and simple models of life cycle patterns. This approach may help such enterprises establish and maintain sustainable growth.
Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth
An important agenda of pharmaceutical companies is the establishment of therapeutic area strategies, drug modality, and geographic strategies for research and development. It is worthwhile to understand the changes in therapeutic area, modality and internationalization of the top-selling pharmaceutical drugs over the past. Hence, the purposes of this study are to investigate changes in therapeutic area, modality and internationalization of the top-selling drugs and to identify their life cycle patterns. We compared the top-selling drugs between 2011 and 2017, and found that the percentages of nichebuster cancer drugs and home region-oriented drugs have increased whereas the proportions of traditional blockbuster cardiovascular drugs and global drugs have decreased. We compared product life cycle patterns via a Kruskal–Wallis test, and identified the features of product life cycle patterns per therapeutic area and modality. We performed a case study on drugs in the same class with the same pharmacological mechanism but found no differences across cases. Our results provide insights into therapeutic area strategies that consider life cycle patterns and geographic strategies that consider the competitive advantages of home region-oriented drugs. Finally, we presented new and simple models of life cycle patterns. This approach may help such enterprises establish and maintain sustainable growth.
Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth
Fumio Teramae (author) / Tomohiro Makino (author) / Shintaro Sengoku (author) / Yeongjoo Lim (author) / Takashi Natori (author) / Kota Kodama (author)
2020
Article (Journal)
Electronic Resource
Unknown
Metadata by DOAJ is licensed under CC BY-SA 1.0
Product life cycle assessment for sustainable building
| British Library Conference Proceedings | 1999
The Role of Life Cycle Assessment in Sustainable Product Certification
| British Library Online Contents | 2005
The Role of Life Cycle Assessment in Sustainable Product Certification
| British Library Online Contents | 2005
The Role of Life Cycle Assessment in Sustainable Product Certification
| Online Contents | 2005
Sustainable Solutions for Wearable Technologies: Mapping the Product Development Life Cycle
| DOAJ | 2020